Works matching IS 10834389 AND DT 2023 AND VI 28 AND IP 1
Results: 12
A comprehensive evaluation of an animal model for Helicobacter pylori‐associated stomach cancer: Fact and controversy.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12943
- By:
- Publication type:
- Article
Transmission routes and patterns of helicobacter pylori.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12945
- By:
- Publication type:
- Article
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12944
- By:
- Publication type:
- Article
Helicobacter pylori, gastrointestinal microbiota, and immunotherapy.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12942
- By:
- Publication type:
- Article
Helicobacter pylori regulated microRNA map of human gastric cells.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12941
- By:
- Publication type:
- Article
Quadruple therapy with vonoprazan 20 mg daily as a first‐line treatment for Helicobacter pylori infection: A single‐center, open‐label, noninferiority, randomized controlled trial.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12940
- By:
- Publication type:
- Article
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12939
- By:
- Publication type:
- Article
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12935
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12901
- Publication type:
- Article
Discussion on the common controversies of Helicobacter pylori infection.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12938
- By:
- Publication type:
- Article
Evaluation of guidelines for diagnosis and treatment of Helicobacter pylori infection.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12937
- By:
- Publication type:
- Article
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis.
- Published in:
- Helicobacter, 2023, v. 28, n. 1, p. 1, doi. 10.1111/hel.12936
- By:
- Publication type:
- Article